(3R,4S,1'S)-3-hydroxy-4-methoxycarbonyl-1-(1'-phenylethyl)pyrrolidin-2-one | 807626-29-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯烷类
• 英文名称: (3R,4S,1'S)-3-hydroxy-4-methoxycarbonyl-1-(1'-phenylethyl)pyrrolidin-2-one
• 英文别名: methyl (3S,4R)-4-hydroxy-5-oxo-1-[(1S)-1-phenylethyl]pyrrolidine-3-carboxylate
• CAS: 807626-29-5
• 化学式: C₁₄H₁₇NO₄
• 分子量: 263.293
• InChiKey: NRCHLBDBBLGGOV-ZMLRMANQSA-N

物化性质

• 沸点：
  445.5±45.0 °C(Predicted)
• 密度：
  1.275±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  19
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  66.8
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  (3R,4S,1'S)-3-hydroxy-4-methoxycarbonyl-1-(1'-phenylethyl)pyrrolidin-2-one 在 咪唑 、 甲醇 、 4-二甲氨基吡啶 、 lithium aluminium tetrahydride 、 氯甲酸氯乙酯 、 三乙胺 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 15.17h， 生成 (3R,4R)-3-hydroxy-4-(hydroxymethyl)pyrrolidine
  参考文献：
  名称：

  Chiral 3-hydroxypyrrolidin-2-ones from a Baylis–Hillman adduct: convergent, stereoselective synthesis of a glycosidase inhibitor

  摘要：

  The O-silyl derivative 4b, prepared starting from the Baylis-Hillman adduct 4a, underwent cyclization on treatment with (S)-phenylethylamine, to give to an equimolar mixture of the 4,5-cis-disubstituted pyrrolidin-2-ones 9 and 10, exclusively, which after separation by silica gel chromatography were both converted into the 3-hydroxy-4-hydroxymethylpyrrolidine 1 a glycosidase inhibitor. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetasy.2004.08.016
• 作为产物：
  描述：

  1-Ethyl 4-methyl 2-hydroxy 3-methylenebutanedioate 在 咪唑 、 盐酸 、 1,8-二氮杂双环[5.4.0]十一碳-7-烯 作用下， 以 甲醇 、 二氯甲烷 、 甲苯 为溶剂， 反应 56.0h， 生成 (3R,4S,1'S)-3-hydroxy-4-methoxycarbonyl-1-(1'-phenylethyl)pyrrolidin-2-one
  参考文献：
  名称：

  Chiral 3-hydroxypyrrolidin-2-ones from a Baylis–Hillman adduct: convergent, stereoselective synthesis of a glycosidase inhibitor

  摘要：

  The O-silyl derivative 4b, prepared starting from the Baylis-Hillman adduct 4a, underwent cyclization on treatment with (S)-phenylethylamine, to give to an equimolar mixture of the 4,5-cis-disubstituted pyrrolidin-2-ones 9 and 10, exclusively, which after separation by silica gel chromatography were both converted into the 3-hydroxy-4-hydroxymethylpyrrolidine 1 a glycosidase inhibitor. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetasy.2004.08.016

文献信息

• Fused substituted aminopyrrolidine derivative
  申请人：Takahashi Hisashi

  公开号：US20120108582A1

  公开（公告）日：2012-05-03

  A quinolone synthetic antibacterial agent having excellent properties as a medicine is provided, which has strong antibacterial activity not only to Gram-negative bacteria but also to Gram-positive cocci that have low sensitivity to quinolone antibacterial agents, and which exhibits high safety and excellent pharmacokinetics. A compound represented by the formula (I) or a salt thereof, or a hydrate thereof. Specifically, a quinolone derivative of the formula (I) wherein substituents R6 and R7 taken together with the carbon atoms to which they are bonded form a cyclic structure which may contain an oxygen atom as a ring constituent atom, the cyclic structure forming a 5-4, 5-5, or 5-6 fused bicyclic pyrrolidinyl substituent, the substituent being bonded to a quinolone mother skeleton Q containing a pyridobenzoxazine structure.

  提供了一种具有极好药物特性的喹诺酮合成抗菌剂，其不仅对革兰氏阴性菌具有强烈的抗菌活性，而且对对喹诺酮抗菌剂敏感度较低的革兰氏阳性球菌也具有强烈的抗菌活性，并表现出高安全性和优异的药代动力学特性。该化合物由式(I)或其盐或水合物表示，具体而言，是式(I)的喹诺酮衍生物，其中取代基R6和R7与它们所连接的碳原子一起形成一个环状结构，该环状结构可能包含一个氧原子作为环状成分原子，该环状结构形成一个5-4、5-5或5-6融合的双环吡咯烷基取代物，该取代物与含有吡啶苯并噁嗪结构的喹诺酮母骨架Q连接。
• Fused Substituted Aminopyrrolidine Derivative
  申请人：Daiichi Sankyo Company, Limited

  公开号：US20140142096A1

  公开（公告）日：2014-05-22

  A quinolone synthetic antibacterial agent having excellent properties as a medicine is provided, which has strong antibacterial activity not only to Gram-negative bacteria but also to Gram-positive cocci that have low sensitivity to quinolone antibacterial agents, and which exhibits high safety and excellent pharmacokinetics. A compound represented by the formula (I) or a salt thereof, or a hydrate thereof. Specifically, a quinolone derivative of the formula (I) wherein substituents R6 and R7 taken together with the carbon atoms to which they are bonded form a cyclic structure which may contain an oxygen atom as a ring constituent atom, the cyclic structure forming a 5-4, 5-5, or 5-6 fused bicyclic pyrrolidinyl substituent, the substituent being bonded to a quinolone mother skeleton Q containing a pyridobenzoxazine structure.

  提供了一种具有出色药物特性的喹诺酮合成抗菌剂，它不仅对革兰氏阴性菌具有强烈的抗菌活性，而且对对喹诺酮抗菌剂敏感性较低的革兰氏阳性球菌也具有强烈的抗菌活性，并且具有高安全性和优异的药代动力学。化合物由式(I)或其盐或其水合物表示，具体来说，是式(I)的喹诺酮衍生物，其中取代基R6和R7与它们连接的碳原子一起形成一个环状结构，该环状结构可以包含一个氧原子作为环构成原子，该环状结构形成一个5-4、5-5或5-6融合的双环吡咯烷基取代基，该取代基与含有吡啶并苯并噁嗪结构的喹诺酮母骨架Q连接。
• FUSED SUBSTITUTED AMINOPYRROLIDINE DERIVATIVE
  申请人：Daiichi Sankyo Company, Limited

  公开号：EP2097400B1

  公开（公告）日：2013-07-03
• [EN] FUSED SUBSTITUTED AMINOPYRROLIDINE DERIVATIVE<br/>[FR] DÉRIVÉ D'AMINOPYRROLIDINE SUBSTITUÉ LIÉ PAR FUSION
  申请人：DAIICHI SANKYO CO LTD

  公开号：WO2008082009A2

  公开（公告）日：2008-07-10

  [EN] A quinolone synthetic antibacterial agent having excellent properties as a medicine is provided, which has strong antibacterial activity not only to Gram-negative bacteria but also to Gram-positive cocci that have low sensitivity to quinolone antibacterial agents, and which exhibits high safety and excellent pharmacokinetics. A compound represented by the formula (I) or a salt thereof, or a hydrate thereof. Specifically, a quinolone derivative of the formula (I) wherein substituents R6 and R7 taken together with the carbon atoms to which they are bonded form a cyclic structure which may contain an oxygen atom as a ring constituent atom, the cyclic structure forming a 5-4, 5-5, or 5-6 fused bicyclic pyrrolidinyl substituent, the substituent being bonded to a quinolone mother skeleton Q containing a pyridobenzoxazine structure.
  [FR] L'invention concerne un agent antibactérien synthétique de type quinolone présentant d'excellentes propriétés thérapeutiques, cet agent développant une forte activité antibactérienne, non seulement par rapport aux bactéries à Gram négatif, mais aussi par rapport aux cocci à Gram positif qui sont peut sensibles aux agents antibactériens de type quinolone, ledit agent présentant un niveau de sécurité élevé et d'excellentes propriétés de pharmacocinétique. L'invention concerne aussi un composé de formule (I) ou un sel de celui-ci ou bien un hydrate de celui-ci. L'invention porte en particulier sur un dérivé de quinolone de formule (I) dans laquelle les susbtituants R6 et R7, avec les atomes carbones auxquels ils sont liés, forment une structure cyclique qui peut contenir un atome d'oxygène en tant qu'atome constituant un noyau, la structure cyclique formant un substituant de pyrrolidinyle bicyclique lié par fusion 5-4, 5-5 ou 5-6, ce substituant étant lié à un squelette mère de quilonone Q comportant une structure pyridobenzoxazine: (I).